Subscribe Us

header ads

Recents

header ads

Mammography Market Size At Around US$ 4.8 Bn In 2030

The mammography market would grow at a CAGR of 8.01% over the predicted time frame. The market is expected to increase in value from US$ 2.59 Bn in 2022 to US$ 4.8 Bn in 2030.

Mammography Market Size 2022 to 2030

Key Takeaways: 

  • By product, U.S. mammography market was valued at USD 659 million in 2021 and is registering growth at a CAGR of 9.7% from 2022 to 2030.
  • North America ruled the market and represented the biggest share of around 42% in 2021. 
  • The breast tomosynthesis technology segment is projected to grow at a CAGR of 6.3% from 2022 to 2030.
  • By technology, the digital mammography innovation segment accounted 68% revenue share in 2021.
  • By product, the digital systems segment has garnered 62% market share in 2021.
  • The 3D systems product segment is expected to reach at a 8.4% over the forecast period.

The on mammography Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1854

Report Scope of the Mammography Market

Report CoverageDetails
Market Size by 2030USD 4.8 Billion
Growth Rate from 2022 to 2030

CAGR of 8.01%

North America Market Share in 202142%
Digital Mammography Innovation Segment Market Share in 202168%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct, Technology, Modality, End Use, Geography

A recent report provides crucial insights along with application based and forecast information in the Global Mammography Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Mammography market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Mammography market are included as given below:

Mammography Market Key Players

  • Hologic
  • Fujifilm
  • Siemens Healthcare
  • Phillips Healthcare
  • Toshiba Medical Systems
  • GE Healthcare
  • Metaltronica
  • I.M.S. Srl
  • Koninklijke Philips NV
  • Gamma Medica, Inc.
  • Konica Minolta Business Solutions India Private Limited
  • Carestream Health.
  • BMI Biomedical International SRL
  • Canon Inc
  • MetaltronicaSpA, PLANNED OY
  • GENERAL MEDICAL ITALIA
  • Villa Systems Medical SpA

Market Segments

By Product

  • Film Screen Systems
  • Digital Systems
  • Analog Systems
  • Biopsy Systems
  • 3D Systems
  • Others

By Technology

  • Breast Tomosynthesis Mammography
  • CAD Mammography
  • Digital Mammography

By Modality

  • Portable
  • Non-Portable

By End Use

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Report Objectives

  • To define, describe, and forecast the global mammography market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the mammography market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mammography Market 

5.1. COVID-19 Landscape: Mammography Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mammography Market, By Product

8.1. Mammography Market, by Product, 2022-2030

8.1.1. Film Screen Systems

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Digital Systems

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Analog Systems

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Biopsy Systems

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. 3D Systems

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Mammography Market, By Technology

9.1. Mammography Market, by Technology e, 2022-2030

9.1.1. Breast Tomosynthesis Mammography

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. CAD Mammography

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Digital Mammography

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Mammography Market, By Modality 

10.1. Mammography Market, by Modality, 2022-2030

10.1.1. Portable

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Non-Portable

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Mammography Market, By End Use 

11.1. Mammography Market, by End Use, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Special Clinics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Diagnosis Centers

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Educational & Research Institutes

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 13. Company Profiles

13.1. Hologic

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Fujifilm

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthcare

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Phillips Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Toshiba Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GE Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Metaltronica

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. I.M.S. Srl

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Koninklijke Philips NV

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Gamma Medica, Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments